Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaireIlse M Nauta, Lisanne J Balk, Judith M Sonder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Natalizumab concentrations during pregnancy in three patients with multiple sclerosisAlyssa A Toorop, Theo Rispens, Eva Mm Strijbis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2024
Understanding the complex network of objectively assessed cognition and self-reported psychological symptoms in people with multiple sclerosisMaureen van Dam, Jantine G Röttgering, Ilse M Nauta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2016
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theoryLidwine Brigitta Mokkink, Francisca Galindo-Garre, Bernard Mj Uitdehaag
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2023
Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosisShira Simon, Ilse M Nauta, Arjan Hillebrand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2018
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item versionMichiel Aj Luijten, Iris Eekhout, Marie D'Hooghe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up studyAxel Petzold, Martijn D Steenwijk, Judith M Eikelenboom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ)Caspar Ep van Munster, Levent Kaya, Morgan Obura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2020
Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosisIlse M Nauta, Shanna D Kulik, Lucas C Breedt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemicZoë Ygj van Lierop, Alyssa A Toorop, Wouter Jc van Ballegoij, et al.
Pageof 11